As of May 28, 2025, Mediclinic International PLC (MDC.L) reports a EV/EBITDA of 11.71.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Mediclinic International PLC's EV/EBITDA to Peers
To better understand Mediclinic International PLC's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Mediclinic International PLC (MDC.L) | 11.71 |
| Swissmed Centrum Zdrowia SA (SWD.WA) | 52.25 |
| MATERNUS-Kliniken-AG (MAK.DE) | 31.08 |
| Aevis Victoria SA (AEVS.SW) | 25.58 |
| M1 Kliniken AG (M12.DE) | 10.87 |
| EMC Instytut Medyczny SA (EMC.WA) | 9.53 |
Compared to its competitors, Mediclinic International PLC's EV/EBITDA is among the highest compared to peers, suggesting the market values the company at a premium, possibly due to growth expectations.